Want to see IN:KRONOX full AI Analyst Report?
KRONOX Stock Chart & Stats
₹133.19
₹3.45(1.73%)
At close: 4:00 PM EST
₹133.19
₹3.45(1.73%)
Day’s Range― - ―
52-Week Range₹96.00 - ₹222.90
Previous CloseN/A
Volume58.78K
Average Volume (3M)98.74K
Market Cap
₹6.83B
Enterprise Value₹3.15K
Total Cash (Recent Filing)₹487.41M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)23.8
Beta1.17
Next Earnings
Nov 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.27%
Share Statistics
EPS (TTM)7.74
Shares Outstanding37,104,000
10 Day Avg. Volume54,241
30 Day Avg. Volume98,736
Financial Highlights & Ratios
PEG Ratio1.86
Price to Book (P/B)3.65
Price to Sales (P/S)4.19
P/FCF Ratio20.58
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong ProfitabilityRising net income and a strong net margin indicate effective cost control and operating efficiency. This profitability provides internal funding capacity and supports resilience if revenue growth remains modest.
Low Financial LeverageA very low debt burden limits interest and refinancing risk, preserving financial flexibility for investment or expansion. The enlarged equity and asset base also strengthens the company’s ability to absorb operating volatility.
Healthy Cash GenerationPositive operating and free cash flow show that reported earnings convert into cash, supporting reinvestment, working-capital needs and financial independence. This strengthens the quality and durability of the company’s profitability.
Bears Say
Limited Revenue GrowthNearly flat reported revenue indicates limited recent expansion in the underlying business. Without clearer evidence of sustained demand growth, future earnings increases may depend more on efficiency than on broadening sales.
Declining Cash FlowThe year-over-year reduction in operating and free cash flow could reflect working-capital or investment pressure. If persistent, weaker cash conversion may constrain reinvestment and reduce the cushion supporting earnings quality.
Debt IncreasedAlthough leverage remains very manageable, the move from no debt to funded borrowing introduces a new financing obligation. Continued increases without corresponding cash-flow improvement could gradually reduce the balance sheet’s former conservatism.
Kronox Lab Sciences Limited News
KRONOX FAQ
What was Kronox Lab Sciences Limited’s price range in the past 12 months?
Kronox Lab Sciences Limited lowest stock price was ₹96.00 and its highest was ₹222.90 in the past 12 months.
What is Kronox Lab Sciences Limited’s market cap?
Kronox Lab Sciences Limited’s market cap is ₹6.83B.
When is Kronox Lab Sciences Limited’s upcoming earnings report date?
Kronox Lab Sciences Limited’s upcoming earnings report date is Nov 17, 2026 which is in 69 days.
How were Kronox Lab Sciences Limited’s earnings last quarter?
Kronox Lab Sciences Limited released its earnings results on Aug 12, 2026. The company reported ₹1.968 earnings per share for the quarter.
Is Kronox Lab Sciences Limited overvalued?
According to Wall Street analysts Kronox Lab Sciences Limited’s price is currently Overvalued.
Does Kronox Lab Sciences Limited pay dividends?
Kronox Lab Sciences Limited pays a Annually dividend of ₹0.5 which represents an annual dividend yield of 0.27%. See more information on Kronox Lab Sciences Limited dividends here
What is Kronox Lab Sciences Limited’s EPS estimate?
Kronox Lab Sciences Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kronox Lab Sciences Limited have?
Kronox Lab Sciences Limited has 37,104,000 shares outstanding.
What happened to Kronox Lab Sciences Limited’s price movement after its last earnings report?
Kronox Lab Sciences Limited reported an EPS of ₹1.968 in its last earnings report. Following the earnings report the stock price went up 3.886%.
Which hedge fund is a major shareholder of Kronox Lab Sciences Limited?
Currently, no hedge funds are holding shares in IN:KRONOX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Kronox Lab Sciences Limited
Kronox Lab Sciences Ltd. operates as a manufacturer and global supplier of a diverse range of chemical products, encompassing fine chemicals, inorganic compounds, phosphates, and metallic chemicals, serving markets both within India and worldwide. Its extensive product portfolio is categorized into three main segments. Firstly, it offers a selection of bulk reagents, such as ACS, LR, AR, and GR grades, essential for various laboratory and industrial applications. Secondly, the company supplies bulk ingredients catering to numerous industries, including oral care, pharmaceuticals (pharmacopoeia), food and nutraceuticals, personal care and cosmetics, and veterinary medicine for animal health. Lastly, its specialty chemicals division features a wide array of specialized compounds like tartrates, citrates, hypophosphites, phosphates, hydroxides, EDTA and its derivatives, ultra-high purity chemicals, custom-specified formulations, and anhydrous specialty products, alongside solutions for heat treatment, quenching, and eutectic salt applications. Established in 2008, Kronox Lab Sciences Limited has its headquarters situated in Vadodara, India.
Technical Analysis
Asahi Songwon Colors Ltd.
―
Chembond Chemicals Limited
―
DIC India Limited
―
Mangalam Organics Ltd
―
Poddar Pigments Limited
―